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Cervical pregnancy can be complicated by perfuse vaginal bleeding. Mechanical compression directed at tamponing the cervical
vessels can control hemostasis. There are several types of balloon catheters that have been described for cervical compression.
However use of a double balloon catheter is a novel approach for cervical tamponade, as one balloon is positioned below the external
cervical os and the second balloon is situated above in the internal cervical os. This compresses the cervix from internal os to external
os between the two balloons, forming a “cervical sandwich.” We describe this method of cervical tamponade using a silicone
double balloon cervical ripening catheter that rapidly controlled hemorrhage in a patient that failed conservative management
with methotrexate.

1. Introduction
Cervical pregnancy (CP) is a rare type of ectopic pregnancy
characterized by implantation of a fertilized ovum in the
endocervical canal. CP accounts for less than 1% of all
ectopic pregnancies [1–3]. Risk factors include endometrial
damage after curettage or chronic endometritis, leiomyoma,
intrauterine devices, and in vitro fertilization [2, 4, 5].
This type of ectopic pregnancy is highly dangerous because
massive hemorrhage can ensue secondary to bleeding from
the cervical vessels. Early detection has been improved by
ultrasonography. However, even with advanced diagnostic modalities and treatment options, CP remains a lifethreatening condition.
During the last decade, in an effort to avoid hysterectomy and maintain fertility, a more conservative therapeutic
approach has been advocated. This includes chemotherapy with methotrexate, intra-amniotic feticide, dilation and
curettage, uterine tamponade, and uterine artery embolization [5, 6]. Usually more than one modality of treatment
is necessary [2, 7]. We describe a novel method of cervical
tamponade using a silicone double balloon cervical ripening
catheter (Cook Cervical Ripening Balloon, Cook Medical,

Bloomington, Indiana) in a patient that presented with acute
hemorrhage after conservative management with systemic
chemotherapy.

2. Case
A 31-year-old gravida 2 para 0 at 7 weeks and 3 days presented
to the emergency room with complaints of vaginal bleeding
and abdominal cramping that began earlier that morning. On
examination, her abdomen was nontender without rebound
or guarding. No active bleeding was noted vaginally. Her
serum beta human chorionic gonadotrophin (𝛽-hCG) was
18,645 mIU/L.
Transvaginal ultrasound revealed a 22 mm gestational
sac implanted within the cervical canal with a fetal pole
but no fetal cardiac activity. Decision was made to admit
patient for systemic multidose methotrexate regimen for
conservative management of a cervical pregnancy. Uterine
artery embolization was considered but concern arose about
long term effects on the patient’s future fertility.
Methotrexate 85 mg (1 mg/kg) was administered on days
1, 3, 5, and 7. Rescue leucovorin 8.5 mg (0.1 mg/kg) was
administered on days 2, 4, 6, and 8. Her 𝛽-hCG levels on days
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1, 3, 5, and 7 were 18,645 IU/mL, 15,527 IU/mL, 15,099 IU/mL,
12,718 IU/mL, and 10,222 IU/mL, respectively. On hospital
day 7, repeat transvaginal ultrasonography showed a collapsing gestational sac with no visible yolk sac or fetal pole.
The patient experienced no further vaginal bleeding during
admission. The patient was discharged home with plan of
having weekly 𝛽-hCG measured until levels declined to zero.
The patient returned to the emergency room two days
after discharge with heavy vaginal bleeding. On examination,
approximately 300 mL of blood was cleared from the vaginal
vault. The vaginal vault was packed with gauze in an attempt
to tamponade bleeding so that patient could be safely transported to the operating room for an examination under anesthesia. At the time of the patient’s presentation to emergency
room, interventional radiology was not readily available
to perform uterine artery embolization. After removal of
vaginal packing, approximately 500 mL of additional vaginal
bleeding was noted. Dilation and suction curettage was
performed in order to excise the remaining trophoblast tissue
that was readily visualized at the cervical os. After curettage,
the patient continued to actively hemorrhage. A silicone
double balloon cervical ripening catheter (Cook Cervical
Ripening Balloon) was introduced into the cervical canal
(Figures 1 and 2). 80 mL of normal saline was inserted in
the uterine valve and 60 mL of normal saline inserted in
was introduced into the vaginal valve. Upon insufflation,
the cervix was compressed between the two balloons of the
catheter and hemostasis was rapidly achieved (Figures 3 and
4). Positioning of the Cook Balloon was ascertained by visual
inspection and by gentle traction. Gentle traction insured
that the uterine balloon of the Cook catheter was securely
positioned above the internal os after insufflation. Once the
uterine balloon was determined to be in the appropriate place,
the vaginal valve was insufflated under direct visualization.
Due to the acuity and urgency to stabilize the patient and to
minimize bleeding, imaging to document placement could
not be performed during the procedure.
The patient was observed overnight and reexamined the
following morning. No further bleeding was noted and the
patient remained hemodynamically stable. The compression
balloon was removed without difficulty after 12 hours. The
patient received two doses of tranexamic acid (1000 mg)
approximately 18 hours apart after removal of Cook Balloon.
The patient was discharged the following day in stable
condition. 𝛽-hCG repeated 24 days after discharge from the
hospital was 2 IU/mL.

3. Discussion
The early diagnosis of cervical ectopic pregnancy in our
patient was made by confirming the following ultrasound
criteria: (1) an empty uterine cavity above the level of the
internal cervical os (Figure 5), (2) barrel-shaped cervix
(Figure 6), (3) gestational sac located below the level of
the uterine arteries, and (4) vascularization around the
gestational sac demonstrated by Doppler color flow ultrasonography (Figure 7) [7, 8]. Cervical pregnancy can be
distinguished from an imminent aborting pregnancy within
the cervix by the absence of the “sliding sign” (elicited when
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Figure 1: Cook Balloon Inflated with 80 mL saline in the uterine
balloon and 60 mL saline in vaginal balloon.

Figure 2: Distance between the two balloons can be stretched
approximately 5 cm.

mechanical pressure from the ultrasound transducer causes
the gestational sac to slide against the endocervical canal in
case of imminent abortion but not in an implanted CP) [7].
Although there are no definitive guidelines for the management of cervical pregnancies, a variety of modalities have
been proposed [4]. Approaches include curettage combined
with Foley balloon tamponade, methotrexate with/without
potassium chloride injection, uterine artery embolization,
and ligation of cervical branches of uterine arteries. The most
commonly reported medical treatments are methotrexate, by
either local injection (intra-amniotic or intrafetal) or systemic administration [6, 9, 10]. The outcome of conservative
management with methotrexate has been reported to be
relatively safe and effective, allowing for uterine preservation
in more than 90% of cases treated before 12 weeks of gestation
[6, 9, 10].
In the case presented, the patient desired to preserve fertility. Inpatient conservative therapy with multidose methotrexate was elected. Although her 𝛽-hCG levels
declined appropriately over the course of her treatment,
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Figure 5: Empty uterus with gestational sac (GS) in cervix.
Figure 3: Placement of balloons in uterus and vagina (picture from
package insert).

Figure 6: Gestational sac with yolk sac and fetal pole within the
cervix.

Figure 4: Illustration of “sandwich effect” of the two inflated
balloons. Note that space between the balloons is stretchable and
can accommodate the entire cervix.

she re-presented with profuse bleeding per vagina. In the
event of hemorrhage following failed medical therapy or
postsuction curettage, mechanical compression or tamponade of the cervix can rapidly restore hemostasis [7, 11].
There are several types of balloon catheters that have been
described for cervical compression in the literature [12].
These include the Bakri Balloon (Cook Medical, Bloomington, Indiana), Rusch hydrostatic catheter (Teleflex Medical
Sdn Bhd, Kamuntung, Malaysia), condom catheters, and
Foley catheters [12]. Fylstra describes treatment of cervical
pregnancy being achieved successfully in 13 patients by curettage immediately followed by placement of 30 mL balloon
Foley catheter for tamponade; tamponade was left in place
for 24 hours [13]. The use of Foley balloon has also been cited
to prophylactically control bleeding in cervical pregnancies
[13, 14]. Similarly, Timor-Tritsch successfully treated cervical
and cesarean scar ectopic pregnancies with double balloon
catheter [15]. The double balloon catheter provided compression to terminate pregnancy and prevent bleeding. Our case
report defers from both Fylstra and Timor-Tritsch in that use
of double balloon catheter was to control hemorrhage with
tamponade, not to prophylactically prevent hemorrhage nor
to treat a live ectopic pregnancy.

As an alternative to the Foley catheter, in our patient,
tamponade and further hemostasis were created with the
Cook Balloon by the insufflation of the internal and external
balloon, respectively. Although the Cook Balloon is normally
used for cervical ripening for induction of labor, its use has
been reported for the management of postabortal hemorrhage [12]. Unlike other compression devices such as the
Foley balloon, the Cook catheter consists of a double balloon
system. This allows for one balloon to be positioned below
the internal-external cervical os and the second balloon
to be situated above in the internal cervical os (Figure 1).
Tamponade with a double balloon cervical ripening catheter
has not been previously described to control hemorrhage in
CP. The double balloon additionally adjusts to the length of
the cervix prior to insufflation allowing for compression from
internal to external os (Figure 2). A double balloon catheter,
as used in our case, may be considered to control hemorrhage
for CP as it was able to quickly create a tamponade by
compressing the cervix from the internal to external os.
Tranexamic acid (TXA) in the case presented was used
prophylactically to prevent any further event of hemorrhage.
Tranexamic acid is a potent antifibrinolytic agent that exerts
its effect by competitively blocking lysine binding sites on
plasminogen molecules [16]. This prevents the binding of
fibrin to plasminogen and therefore impairs fibrinolysis [16].
The use of TXA in cervical pregnancy has limited discussion in literature. However, the use of TXA in postpartum
hemorrhage and trauma is a field of evolving study [17].
Clinically, TXA has been shown to decrease the need of
blood transfusions, reoperation for bleeding, and mean of
transfused units [17]. TXA’s use for menorrhagia has shown
to reduce mean blood loss, which may suggest a possible link
in reducing uterine blood flow [18].
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Figure 7: Vascularization around the gestational sac demonstrated
by Doppler color flow.

[10]

4. Conclusion
The case presented delineates the use of conservative management and complications of cervical pregnancy. The use
of methotrexate is well documented in literature for the
treatment of cervical pregnancy. However, the use of a double
balloon cervical ripening catheter (Cook Balloon) to achieve
cervical tamponade during hemorrhage has limited citing in
literature. In cases where future fertility is of greatest concern,
the Cook Balloon may serve as an option for decreasing
blood loss. Furthermore, the use of TXA to prevent future
hemorrhage and decrease the need for reoperation is a
possible consideration when patient’s desire to maintain
fertility is a major concern. The prophylactic use of TXA is
not well established in cervical pregnancies and future studies
are needed to demonstrate its effectiveness.
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